These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18479922)

  • 1. The impact of aromatase inhibitors on sexual functioning: current knowledge and future research directions.
    Mok K; Juraskova I; Friedlander M
    Breast; 2008 Oct; 17(5):436-40. PubMed ID: 18479922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G
    Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey among breast cancer survivors: treatment of the climacteric after breast cancer.
    Antoine C; Vandromme J; Fastrez M; Carly B; Liebens F; Rozenberg S
    Climacteric; 2008 Aug; 11(4):322-8. PubMed ID: 18645698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing the toxicities of the aromatase inhibitors.
    Mortimer JE
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):56-60. PubMed ID: 20019610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
    Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
    J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
    Buchholz S; Mögele M; Lintermans A; Bellen G; Prasauskas V; Ortmann O; Grob P; Neven P; Donders G
    Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.
    Ewer MS; Glück S
    Cancer; 2009 May; 115(9):1813-26. PubMed ID: 19235248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatase inhibitors and musculoskeletal symptoms.
    Khanduri S; Dodwell DJ
    Breast; 2008 Feb; 17(1):76-9. PubMed ID: 17822901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
    Chlebowski RT
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer.
    Iwase H
    Breast Cancer; 2008; 15(4):278-90. PubMed ID: 18810576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
    Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
    Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors for adjuvant treatment of postmenopausal breast cancer.
    Med Lett Drugs Ther; 2011 Jun; 53(1366):47-8. PubMed ID: 21659970
    [No Abstract]   [Full Text] [Related]  

  • 13. A qualitative exploration of the impact of yoga on breast cancer survivors with aromatase inhibitor-associated arthralgias.
    Galantino ML; Greene L; Archetto B; Baumgartner M; Hassall P; Murphy JK; Umstetter J; Desai K
    Explore (NY); 2012; 8(1):40-7. PubMed ID: 22225932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?
    Miller WR; Bartlett J; Brodie AM; Brueggemeier RW; di Salle E; Lønning PE; Llombart A; Maass N; Maudelonde T; Sasano H; Goss PE
    Oncologist; 2008 Aug; 13(8):829-37. PubMed ID: 18695261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Abdulhaq H; Geyer C
    Am J Clin Oncol; 2008 Dec; 31(6):595-605. PubMed ID: 19060594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.
    Advani P; Brewster AM; Baum GP; Schover LR
    J Cancer Surviv; 2017 Aug; 11(4):477-485. PubMed ID: 28229275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M; Yamashiro H; Tsuji W
    Breast Cancer; 2009; 16(3):207-18. PubMed ID: 19259765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer in men: should aromatase inhibitors become first-line hormonal treatment?
    Nordman IC; Dalley DN
    Breast J; 2008; 14(6):562-9. PubMed ID: 19000052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.
    Batalo M; Nagaiah G; Abraham J
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1277-82. PubMed ID: 21916581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia.
    Dizdar O; Ozçakar L; Malas FU; Harputluoglu H; Bulut N; Aksoy S; Ozisik Y; Altundag K
    J Clin Oncol; 2009 Oct; 27(30):4955-60. PubMed ID: 19752344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.